Stockscreener 앱 받기
1.26
14.55%
0.16
시간 외 거래:
1.27
0.01
+0.79%
전일 마감가:
$1.10
열려 있는:
$1.12
하루 거래량:
762.39K
Relative Volume:
5.73
시가총액:
$39.53M
수익:
$90,000
순이익/손실:
$-33.89M
주가수익비율:
-1.1599
EPS:
-1.0863
순현금흐름:
$-24.68M
1주 성능:
+7.69%
1개월 성능:
+13.51%
6개월 성능:
-18.71%
1년 성능:
+0.00%
1일 변동 폭
$1.08
$1.29
1주일 범위
$1.06
$1.29
52주 변동 폭
$0.952
$1.9454
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.26 | 34.51M | 90,000 | -33.89M | -24.68M | -1.0863 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Aug Macro: Is now the right time to enter Actinium Pharmaceuticals Inc2026 Earnings & Fast Exit and Entry Trade Guides - baoquankhu1.vn
ATNM Stock Price, Quote & Chart | ACTINIUM PHARMACEUTICALS INC (NYSEARCA:ATNM) - ChartMill
Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026 - Indian Pharma Post
Aug Highlights: Can Actinium Pharmaceuticals Inc outperform in the next rallyJobs Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Support Test: Is Actinium Pharmaceuticals Inc subject to activist investor interest2026 Weekly Recap & Target Return Focused Picks - baoquankhu1.vn
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting - The AI Journal
Aug Mood: Can Actinium Pharmaceuticals Inc outperform in the next rallyWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
What is HC Wainwright’s Estimate for ATNM FY2026 Earnings? - Defense World
ATNM Shareholders Have Opportunity to Lead Actinium Pharmaceutica - The National Law Review
Research Analysts Set Expectations for ATNM Q1 Earnings - Defense World
Actinium Pharmaceuticals (NYSE:ATNM) Receives “Overweight” Rating from Stephens - Defense World
ATNM: Stephens & Co. Reiterates Overweight Rating with $5.00 Tar - GuruFocus
Actinium Pharmaceuticals 2026 Annual Report: Clinical-Stage Radiopharmaceutical Innovations, Competitive Strengths, and Regulatory Risk Factors - Minichart
Actinium: Q4 Earnings Snapshot - KVUE
Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Actinium Pharmaceuticals (NYSE: ATNM) outlines radiotherapy pipeline, losses and 2026 manufacturing plans - Stock Titan
Actinium Pharmaceuticals (ATNM) Eps Diluted (TTM) - Zacks Investment Research
Portfolio Shifts: What is the dividend yield of Actinium Pharmaceuticals Inc2026 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
Actinium Pharmaceuticals (ATNM) board adopts annual Say-on-Pay advisory votes - Stock Titan
Comparing UCB (OTCMKTS:UCBJF) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Fundamentals Check: Is Actinium Pharmaceuticals Inc undervalued by DCF analysis - baoquankhu1.vn
If You Invested $1,000 in Actinium Pharmac (ATNM) - Stock Titan
Stop Loss: What is the next catalyst for Actinium Pharmaceuticals IncCEO Change & Reliable Breakout Forecasts - baoquankhu1.vn
Analysis Recap: Is Actinium Pharmaceuticals Inc stock good for income investors2026 Market Mood & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Wall Street Recap: Is Actinium Pharmaceuticals Inc stock trending bullishInflation Watch & Reliable Intraday Trade Alerts - baoquankhu1.vn
IPO Launch: Can Actinium Pharmaceuticals Inc stock double in the next year2026 Short Interest & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Shorts: What is the dividend yield of Actinium Pharmaceuticals Inc2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
Market Rankings: Is Actinium Pharmaceuticals Inc undervalued by DCF analysisJuly 2025 Levels & AI Forecast Swing Trade Picks - baoquankhu1.vn
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Analysis Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
ATNM Should I Buy - Intellectia AI
Is now the right time to enter Actinium Pharmaceuticals Inc.Market Activity Recap & AI Based Buy/Sell Signal Reports - mfd.ru
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Performance Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Volume & Verified Stock Trade Ideas - baoquankhu1.vn
ATNM PE Ratio & Valuation, Is ATNM Overvalued - Intellectia AI
Actinium Pharmaceuticals Announces CFO Resignation and New Appointment - TradingView
Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026 - marketscreener.com
Earnings Report: What is the next catalyst for Actinium Pharmaceuticals IncShare Buyback & Safe Capital Growth Stock Tips - baoquankhu1.vn
Actinium Pharmaceuticals (NYSE: ATNM) CFO resigns; CEO adds finance role - Stock Titan
Earnings Risk: What is the next catalyst for Actinium Pharmaceuticals Inc2025 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Profit Recap: Is Actinium Pharmaceuticals Inc stock trending bullish2025 Trade Ideas & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
US Market Wrap: Is now the right time to enter Actinium Pharmaceuticals IncDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
Head-To-Head Contrast: Actinium Pharmaceuticals (NYSE:ATNM) versus Avenue Therapeutics (NASDAQ:ATXI) - Defense World
Rally Mode: What is the next catalyst for Actinium Pharmaceuticals IncQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
What’s the outlook for Actinium Pharmaceuticals Inc.’s sector2025 Market WrapUp & Risk Controlled Swing Alerts - mfd.ru
Contrasting NexImmune (OTCMKTS:NEXI) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Retail Trends: Should I invest in IGM Biosciences Inc before earningsDay Trade & Reliable Price Breakout Alerts - baoquankhu1.vn
Reviewing Actinium Pharmaceuticals (NYSE:ATNM) & Aadi Bioscience (NASDAQ:AADI) - Defense World
Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight - Barchart.com
How Actinium Pharmaceuticals Inc. (7AY1) stock responds to job market shiftsMarket Sentiment Indicators & Free Stay Ahead With Picks - bollywoodhelpline.com
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):